Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Moleculin Biotech CS (MBRX)

Moleculin Biotech CS (MBRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Moleculin Biotech CS 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 USA

P: 713-300-5160 F: 817-394-2127

Description:

Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company which focused on the development of anti-cancer drug candidates. The company's lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin Biotech, Inc. is based in Houston, TX.

Key Statistics

Overview:

Market Capitalization, $K 34,753
Shares Outstanding, K 45,728
Annual Sales, $ 0 K
Annual Net Income, $ -11,880 K
60-Month Beta 1.85
% of Insider Shareholders 11.20%
% of Institutional Shareholders 10.01%
Float, K 40,606
% Float 88.80%

Growth:

1-Year Return -48.30%
3-Year Return -33.91%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 02/20/20
Earnings Per Share ttm -0.32
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 10.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

MBRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.77
Price/Earnings to Growth N/A
Return-on-Equity % -83.40%
Return-on-Assets % -56.62%
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.02
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.72
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar